"We were thrilled to see such a dramatic change even after only a single dose of the new drug. Nearly all of the lab mice's leukemia signs disappeared overnight," said Professor Ben-Neriah.
Resources
-
August 27, 2018
-
August 24, 2018
"Our findings could provide an opportunity to improve future engineering of CAR T cells against tumors...."
-
August 23, 2018
"We believe we've found an approach that is most relevant to humans, in that our models of gene dysfunction mimic the etiology of Parkinson's disease rather than its pathology....
-
August 23, 2018
This opens up new treatment strategies for diseases that involve impairment of the body's ability to break down...
-
August 23, 2018
The breakthrough provides a better understanding of the individualized nature of the disease says the research team.
-
August 22, 2018
-
August 21, 2018
New research shows the benefit of eating fresh fruit on colon diseases like IBD.
-
August 13, 2018
-
August 08, 2018
-
August 08, 2018
A recent UK documentary highlights the need for a service that protects patients and works with their trusted healthcare providers.
-
August 07, 2018
Lower prices negotiated and provided as part of our ongoing mission to make medicines more accessible.
-
August 02, 2018
2018 has been a good year for new cancer treatments says the U.S. AACR.
-
August 02, 2018
Kisqali is now the only CDK4/6 inhibitor for use with an aromatase inhibitor for the treatment of pre-, peri- or postmenopausal women in the US.
-
The approval marks a significant advance in the field of neurology — and one that migraine patients will no doubt welcome.
-
The new preventive medicine for migraine Aimovig (erenumab) has been approved by the EMA. Read more...
-
You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.
-
July 24, 2018
7 need-to-knows about migraine as well as some updates on the latest treatment developments
-
July 20, 2018
-
July 20, 2018
-
July 18, 2018
Find out about what it means to order and receive temperature-controlled medicines.
-
The dramatic before-and-after images show eight men's incredible response to cutting-edge treatment.
-
July 11, 2018
A closer look at the function and efficicacy of niraparib as a maintenace treatment.
-
It’s believed that this immunotherapy and its dual approach to fighting cancer will be a notable complement to existing immuno-oncology treatments.
-
Researchers believe these differences are due to a reduced immunosuppressive tumor environment in older patients.
-
July 04, 2018
The latest approval renders the previous 'temporary approval' a full approval, without further results needed.
-
July 04, 2018
The 52% (95% CI, 41-62) ORR included a complete response rate of 40% and a partial response rate of 12%.
-
July 04, 2018
The FDA has approved a wearable device to treat withdrawal symptoms such as agitation, anxiety, depression, and opiate cravings.
-
July 04, 2018
Researchers say the addition of Keytruda (pembrolizumab) in this study almost doubled the response rate of chemo for patients with NSCLC.
-
July 04, 2018
The study showed that the relative survival gain almost doubled in men, compared to female patients, regardless of the type of cancer and drugs given.
-
Our quarterly review was an opportunity to take stock and support an organisation fuelled by a mission aligned to ours: to make the lives of other human beings better.